Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTON

An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG

NCT00250250 ·Status: COMPLETED ·Phase: PHASE3

Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy

NCT00174187 ·Status: TERMINATED ·Phase: PHASE3

Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin

NCT00488124 ·Status: COMPLETED ·Phase: PHASE2

Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary

NCT00174278 ·Status: COMPLETED ·Phase: PHASE3

Growth Retardation In Children With Special Pathological Conditions Or Disease

NCT00163215 ·Status: COMPLETED ·Phase: PHASE3

Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation

NCT01073605 ·Status: COMPLETED ·Phase: PHASE3

Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature

NCT04798690 ·Status: RECRUITING

Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents

NCT00156143 ·Status: COMPLETED ·Phase: PHASE3

Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome

NCT01604161 ·Status: COMPLETED

Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation

NCT01734447 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

NCT01592500 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device

NCT02018172 ·Status: TERMINATED

Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years

NCT01066052 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age

NCT00557336 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

NCT05894876 ·Status: TERMINATED

A Study to Evaluate Subjects With Turner Syndrome Treated With Growth Hormone

NCT00097552 ·Status: COMPLETED

A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height

NCT00840944 ·Status: UNKNOWN ·Phase: PHASE4

A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency

NCT03305016 ·Status: COMPLETED ·Phase: PHASE3

Growth Response in Girls With Turner Syndrome

NCT01734486 ·Status: COMPLETED ·Phase: PHASE4

Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children

NCT03290235 ·Status: UNKNOWN ·Phase: PHASE4

A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9

NCT05723835 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

NCT07221851 ·Status: RECRUITING ·Phase: PHASE3

Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm

NCT00163189 ·Status: COMPLETED ·Phase: PHASE3

rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency

NCT00572156 ·Status: TERMINATED ·Phase: PHASE2

Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height

NCT00174421 ·Status: COMPLETED ·Phase: PHASE3